GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

FTFT · Mar 31, 2024

Future FinTech Group Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001213900-24-045190General Corporate
Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

2.84% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growth55thOwn-history percentile · N=11
Evidence method

Yoy · gp.fundamentals.revenue

50.94% · CORE · VALID

Gross margin73thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.gross_margin

38.09% · CORE · VALID

Operating margin67thOwn-history percentile · N=15
Evidence method

Level · gp.fundamentals.operating_margin

-49.42% · CORE · VALID

R&D intensityRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

0.01% · OPTIONAL · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History26 statesSelf-history eligible
Period transition

What moved in the state?

Growth Increased
Previous
46.00%
Current
50.94%
Delta
4.95%
Margin Increased
Previous
14.02%
Current
38.09%
Delta
24.07%
Profitability Increased
Previous
-70.05%
Current
-49.42%
Delta
20.62%
R And D Intensity Decreased
Previous
0.98%
Current
0.01%
Delta
-0.97%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.